| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/2005 | EP1496879A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2 |
| 01/19/2005 | EP1496878A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 01/19/2005 | EP1496877A2 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 01/19/2005 | EP1496876A2 Aerosol formulation for inhalation comprising a tiotropium salt |
| 01/19/2005 | EP1496875A1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 01/19/2005 | EP1496874A1 Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers |
| 01/19/2005 | EP1496872A2 Functional foods containing a phospholipid-containing stable matrix |
| 01/19/2005 | EP1496868A1 Controlled release pharmaceutical compositions of carbidopa and levodopa |
| 01/19/2005 | EP1496867A1 Drug-complex microparticles and methods of making/using same |
| 01/19/2005 | EP1496866A2 Process for preparing tannate liquid and semi-solid dosage forms |
| 01/19/2005 | EP1496865A1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 01/19/2005 | EP1496864A2 Pharmaceutical composition containing lamotrigine particles of defined morphology |
| 01/19/2005 | EP1496863A2 Preparation and use of a stable formulation of allosteric effector compounds |
| 01/19/2005 | EP1496861A2 Method of inhibiting restenosis |
| 01/19/2005 | EP1496859A1 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 01/19/2005 | EP1496858A1 Inhalation kit comprisung inhalable powder of tiotropium |
| 01/19/2005 | EP1496857A1 Aerosol containing a particulate active substance |
| 01/19/2005 | EP1496855A2 Vegetable substitute for lanolin |
| 01/19/2005 | EP1496844A1 Cosmetic and dermatological washing active preparations containing one or more pregelatinized, cross-linked starch derivatives and one or more ethoxylated oils |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1496836A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 01/19/2005 | EP1496760A1 Acidic compositions comprising protein and fiber and processes of their preparation |
| 01/19/2005 | EP1496759A1 Compositions comprising protein and fatty acid and processes of their preparation |
| 01/19/2005 | EP1496758A1 Compositions comprising milk protein concentrate and fatty acid and processes of their preparation |
| 01/19/2005 | EP1496757A1 Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| 01/19/2005 | EP1496747A1 Method and composition for improving fertility health in female and male animals and humans |
| 01/19/2005 | EP1496744A1 Parasite control in animals |
| 01/19/2005 | EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/19/2005 | EP1496742A1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| 01/19/2005 | EP1418929A4 Simmondsin processing methods and products |
| 01/19/2005 | EP1412332B1 Quinoline derivatives and use thereof as antitumor agents |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | EP1385510A4 Prodigiosin composition for the treatment of rheumatic arthritis |
| 01/19/2005 | EP1377574B1 6-phenylbenzonaphthyridines |
| 01/19/2005 | EP1368348B1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives |
| 01/19/2005 | EP1362053A4 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 01/19/2005 | EP1355633B1 NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate |
| 01/19/2005 | EP1347958B1 Process for preparing distamycin derivatives |
| 01/19/2005 | EP1337254B1 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence |
| 01/19/2005 | EP1318721A4 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions |
| 01/19/2005 | EP1313738A4 Process for the preparation and purification of thiol-containing maytansinoids |
| 01/19/2005 | EP1272199B1 Combination therapies with vascular damaging activity |
| 01/19/2005 | EP1265615B1 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 01/19/2005 | EP1208104B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/19/2005 | EP1200385B1 Crystals of the sodium salt of pravastatin |
| 01/19/2005 | EP1200080A4 Assay for d-serine transport antagonist and use for treating psychosis |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/19/2005 | EP1165493B1 Nitrogen mustard compounds and prodrugs therefor |
| 01/19/2005 | EP1140038B1 Transdermal drug delivery system |
| 01/19/2005 | EP1124562B1 Combination therapy to treat hepatitis b virus |
| 01/19/2005 | EP1121127B1 Oral pharmaceutical compositions containing buprenorphin |
| 01/19/2005 | EP1115478B1 Emollient esters based upon capryl alcohol and isostearic acid |
| 01/19/2005 | EP1100589B1 Use of propionyl l-carnitine and acetyl l-carnitine in the preparation of medicaments with anticancer activity |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | EP1027365B1 Antitumour uridine analogues |
| 01/19/2005 | EP0994880B1 Crystalline macrolides and process for their preparation |
| 01/19/2005 | EP0958293B1 Nanomolar, non-peptide inhibitors of cathepsin d |
| 01/19/2005 | EP0954282B1 Preparation of particles for inhalation |
| 01/19/2005 | EP0941116B1 Use of vegf for the manufacture of a medicament for the treatment or prevention of intimal hyperplasia and delivery device |
| 01/19/2005 | EP0933995B8 Method of treating endothelial injury |
| 01/19/2005 | EP0833899B1 Cis-9,10-octadecenoamidase |
| 01/19/2005 | EP0831813B1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor |
| 01/19/2005 | EP0804074B1 Treating red blood cell solutions with anti-viral agents |
| 01/19/2005 | EP0784429B1 Therapeutic combinations of venous dilators and arterial dilators |
| 01/19/2005 | EP0642335B2 Controlled release preparation containing a salt of morphine |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 01/19/2005 | CN1568365A Composition comprising a lactobacillus pentosus strain and uses thereof |
| 01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
| 01/19/2005 | CN1568328A Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient |
| 01/19/2005 | CN1568325A Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/19/2005 | CN1568324A 1-glyoxylamide indolizines for treating cancer |
| 01/19/2005 | CN1568323A Activator for peroxisome proliferator-activated receptor delta |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 01/19/2005 | CN1568313A Piperidine compounds as muscarinic antagonists |
| 01/19/2005 | CN1568312A Biphenylcarboxamides useful as lipid lowering agents |
| 01/19/2005 | CN1568311A 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/19/2005 | CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/19/2005 | CN1568309A 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/19/2005 | CN1568308A Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
| 01/19/2005 | CN1568307A Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 01/19/2005 | CN1568306A Hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568199A Drugs ameliorating hypo-HDL cholesterolemia |
| 01/19/2005 | CN1568196A Nutrient therapy for immuno-compromised patients |
| 01/19/2005 | CN1568194A Modulation of smooth muscle cell proliferation |
| 01/19/2005 | CN1568191A Light stabilized antimicrobial materials |
| 01/19/2005 | CN1568190A Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 01/19/2005 | CN1568189A [[2-(amino-3, 4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 01/19/2005 | CN1568188A Nociceptin analogs |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1568186A Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1568184A Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome |
| 01/19/2005 | CN1568183A Citalopram for the treatment of elevated blood pressure |
| 01/19/2005 | CN1568182A Compositions for lessening oxidative stress |
| 01/19/2005 | CN1568181A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |